President Biden's executive order to increase access to contraception
In the USA, President Joe Biden will be signing an executive order to expand access to contraception.
The order comes after concerns have been raised about the security of access to contraception since bans on abortion have come into play and the Supreme Court ruling overturning Roe v Wade in 2022.
The aim of the order is to increase avenues for women to gain access to contraception, and to decrease costs associated, as reproductive rights advocates have been campaigning highlighting the barriers women are facing in acquiring contraception, leaving millions of women vulnerable and without contraception.
The ruling could help to encourage private health insurance agents to offer broader coverage and contraception options, such as covering multiple products and increasing efficiency in the process of obtaining appropriate care, all coming under the Affordable Care Act.
The order will also mean increased access to over the counter contraception, increase coverage of contraception through Medicare, promote family planning services through Medicaid, support access to contraception to vulnerable groups and students, and to further research and data collection on contraception access across the USA.
"This action will build on the progress already made under the Affordable Care Act by further reducing barriers that women face in accessing contraception prescribed by their provider," a White House fact sheet on the order proclaimed.
“Today’s announcements build on actions that the Biden-Harris Administration has already taken to protect access to contraception, including in response to two prior Executive Orders directing actions to safeguard access to reproductive health care services” stated the fact sheet.
In 2022, the US House of Representatives, which was largely controlled by the Democratic party at the time, passed a bill to request a law with the aim of protecting women’s access to contraception. However, on consideration by the Senate, the bill was eventually blocked from passing into law by Republican representatives.
As recently as last week, two Senators moved to introduce a new bill to achieve better protection for access to contraception, for this bill to get passed, it will need to be signed off by Democratic-controlled Senate and the Republican-controlled House.
Related News
-
News Women in Pharma: CPHI India – India’s Pharmaceutical Industry and Gender Inclusion Challenges
India’s pharmaceutical industry has emerged as a significant player in the global market, valued at USD 50 billion in FY 2023-2024, according to Frost & Sullivan’s analysis. This sector encompasses a diverse portfolio, including drugs, vacc... -
News Women in Pharma: Advancing Women's Health
Discover the latest innovations in technologies and therapeutics that are revolutionising women's health in our latest CPHI Online Women in Pharma infographic.
-
News Women in Pharma: Bridging Science, Strategy, and Equity in Chemicals and Pharma
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News Women in Pharma: The Final Chapter of 2025
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and ... -
News A Day in the Life of a Senior Director at Boehringer Ingelheim
In our Day in the Life of series we love getting to know the people at the heart of pharma. In this latest interview we speak to Sanobar Syed, Senior Director at Boehringer Ingelheim, about her career and what she feels is most important for the f... -
News Women in Pharma: Revolutionising menstrual care with medical devices
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News Women in Pharma: Quality leadership, quality services
Our monthly Women in Pharma series highlights the influential lives and work of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive. -
News CPHI Podcast Series: Achieving global health equity through innovation
In the latest episode Lucy Chard engages in a compelling conversation with Dr Lengwe Sinkala, a seasoned clinician and Human Factors and User Experience Consultant at ClariMed.